New mRNA Injection for Respiratory Syncytial Virus
The pharmaceutical industry, specifically Moderna, is currently setting its own sights on an mRNA injection for the respiratory syncytial virus, which is also known as RSV. This decision was made after the pharmaceutical industry witnessed the success, better known as “dollar signs”, of the rollout of a Wuhan “vaccine.” It has been reported that the clinical trial…